Re: Reply from Sarah

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

PVLee

Rank: Mail Room [?]

Points: 183 [?]

Votes: 1 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Reply from Sarah

in response to

Re: Reply from Sarah

KayakerBC

posted on Dec 12, 2015 11:45AM

Kayaker...you won't be getting any Newco shares with this proposal. Nothing changes for us except the Company name. It is not a split but only a re-org.

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply